From Th1 to Th2: diabetes immunotherapy shifts gears.
Solimena
M
M
De Camilli
P
P
D000818:Animals; D001324:Autoantigens / Q000627:therapeutic use*; D003922:Diabetes Mellitus, Type 1 / Q000628:therapy*; D004195:Disease Models, Animal; D005968:Glutamate Decarboxylase / Q000627:therapeutic use*; D007167:Immunotherapy; D051379:Mice; D016688:Mice, Inbred NOD; D018417:Th1 Cells / Q000276:immunology*; D018418:Th2 Cells / Q000276:immunology*
D001324:Autoantigens; D005968:Glutamate Decarboxylase